Over the past year, the International Generic and Biosimilar Medicines Association has notched up a number of achievements.
IGBA Seeks To Underline Value And Access
Global Industry Association Chair Explains How It Is Making Its Message Heard
Speaking with Generics Bulletin at the IGBA’s annual conference in February, chair Jonathan Kimball explained how the association is conveying the value of generics and biosimilars to international industry stakeholders.
